Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

NCT00931606 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

30

Enrollment

INDUSTRY

Sponsor class

Stopped administrative reasons (slow patient enrollment)

Conditions

Chemotherapy Induced Anemia

Interventions

BIOLOGICAL: Sotatercept
DRUG: Placebo

Sponsor

Merck Sharp & Dohme LLC